Study types
- article 40
- other 6
- review 1
Condition tags
- endometriosis 38
- mesh:D004715 33
- infertility 7
- adenomyosis 5
- endometrioma 2
- mesh:D004716 1
- bladder_endometriosis 1
Top journals
Frequent coauthors
- Yutaka Osuga 44
- Yojiro Taketani 43
- Kaori Koga 32
- Osamu Yoshino 29
- Yasushi Hirota 28
- Tetsuya Hirata 25
- Miyuki Harada 22
- Osamu Tsutsumi 18
- Chieko Morimoto 17
- Yuri Takemura 17
We performed CT-guided percutaneous uterine biopsy in three females for whom diagnosis by endometrial brushing cytology and endometrial biopsy had proved difficult. In each case, a percutaneous tumor biopsy was performed using CT fluoroscop…
AIM: The aim of this study was to identify factors that can predict clinical course among patients hospitalized with pelvic inflammatory disease (PID). METHODS: Ninety-three patients who needed hospitalization with a diagnosis of PID were …
AIM: The aim of this study was to review diagnostic/therapeutic strategies of umbilical endometriosis managed in our department and evaluate the effectiveness of these strategies. METHODS: Medical records for patients with diagnosis of endo…
PURPOSE: This study aimed to maximize the chance of pregnancy and provide an optimal protocol for infertile female patients of advanced reproductive age as an alternative to in vitro fertilization (IVF)/intracytoplasmic sperm injection (ICS…
Although assisted reproductive technology (ART) is suspected to increase the risk of placenta previa, a life-threatening complication of pregnancy, the reason is poorly understood. We recruited consecutive 318 pregnancies conceived by ART i…
Extragenital endometriosis severely impairs the quality of life for affected women but its standard management has not yet been well established because of its relatively low incidence. As extragenital organs, intestine, followed by urinary…
BACKGROUND: Proteinase-activated receptor 2 (PAR2) is a G-protein-coupled receptor that is activated by several serine proteases. PAR2 activation in endometriotic stromal cells (ESCs) has been implicated in the development of endometriosis …
Objective: The efficacy of diagnostic laparoscopy should be re-considered due to the improved success rate of assisted reproductive technologies (ART). Methods: We retrospectively reviewed clinical records of 126 women who were examined by …
In a novel paradigm of T cell differentiation, type 17 T helper (Th17) cells may play a significant role in endometriosis, a chronic inflammatory disease. However, the mechanism regulating the accumulation of Th17 cells in endometriotic tis…
OBJECTIVE: To determine possible involvement of splice variant 1 (SV1), a variant of the pituitary growth hormone-releasing hormone (GHRH) receptor, in the development of endometriosis. DESIGN: Comparative and laboratory study. SETTING: U…
BACKGROUND: The increase in concentration of osteoprotegerin, an antagonist of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL), in the peritoneal fluid of women with endometriosis may interfere with TRAIL-induced apoptosis i…
Aim: Hysterosalpingography (HSG) is one of the most commonly used methods in order to evaluate the condition of fallopian tubes in infertility clinics. In the present paper, we retrospectively compared the findings of HSG and laparoscopy to…
IL-17A is secreted from Th17 cells, a discovery leading to revision of the mechanism underlying the role of Th1/Th2 in the immune response. Strong evidence suggests that immune responses associated with inflammation are involved in the path…
CONTEXT: Metformin, a widely used treatment for diabetes that improves insulin sensitivity, also has both antiinflammatory properties and a modulatory effect on ovarian steroid production, two actions that have been suggested to be efficaci…
Adiponectin, a pleiotropic cytokine, exerts its effects via the specific receptors AdipoR1 and AdipoR2. Whereas circulating adiponectin concentrations decrease in women with endometriosis and endometrial cancer, possible effects of adiponec…
Both the classic form of the gonadotropin-releasing hormone receptor, GnRH I, and GnRH agonists reportedly have antiproliferative and apoptotic (programmed cell death) effects on cultured endometriotic cells as well as on some cancer cells …